天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai?Medlife?Pharm-Tech?Co.,?Ltd

Firmenname:Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
Telefon:021-59167510
E-Mail:vip@med-life.cn
Nationalit?t:China
URL: www.med-life.cn/
Produkte insgesamt:4997
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50

Produktkatalog

5-Iodo-indirubin-3'-monoxime331467-03-9C16H10IN3O2
Abemaciclib methanesulfonate1231930-82-7C28H36F2N8O3S
Trilaciclib hydrochloride1977495-97-8C24H31ClN8O
6-(Dimethylamino)purine6-Dimethylaminopurin938-55-6C7H9N5
(±)-Enitociclib1610358-53-6C19H18F2N4O2S
CDK5 inhibitor 20-223865317-30-2C19H19N3O
hSMG-1 inhibitor 11e1402452-10-1C26H27N7O3S
KB-0742 dihydrochloride2416874-75-2C16H26ClN5
CP681301865317-32-4C17H22N4O
Senexin A1366002-50-7C17H14N4
Ribociclib succinate hydrate1374639-79-8C27H36N8O5
hSMG-1 inhibitor 11j1402452-15-6C27H28ClN7O3S
XL413 hydrochloride2062200-97-7C14H13Cl2N3O2
SU9516377090-84-1C13H11N3O2
Uliledlimab2378407-27-1
Mupadolimab2451856-97-4
BS-181 hydrochloride1397219-81-6C22H33ClN6
CDK12-IN-32220184-50-7C23H28F2N8O
CDK12-IN-E92020052-55-3C24H30N6O2
CLK1-IN-12123491-32-5C24H16FN5O
DRAK2-IN-1871837-60-4C21H20N4O3
PROTAC CDK2/9 Degrader-12408641-24-5C40H41N13O7
BMS-265246582315-72-8C18H17F2N3O2
Longdaysin1353867-91-0C16H16F3N5
Riviciclib hydrochloride920113-03-7C21H21Cl2NO5
Voruciclib1000023-04-0C22H19ClF3NO5
dCeMM2296771-07-8C16H11ClN6OS
Lerociclib dihydrochloride2097938-59-3C26H35ClN8O
(-)-Enitociclib1610358-59-2C19H18F2N4O2S
CDK9-IN-82105956-51-0C31H32FN7O3
NGR peptide651328-78-8C20H36N10O8S2
Atuveciclib S-Enantiomer250279-81-1C??H??FN?O?S
CDK8-IN-11629633-48-2C11H8F3N3O
Aminopurvalanol A220792-57-4C19H26ClN7O
NVP 231362003-83-6C25H25N3O2S
MBQ-1672097938-73-1C22H18N4
Mevociclib1816989-16-8C31H35ClN8O2
Cdc7-IN-11402055-25-7C21H16ClN3O4
WEE1-IN-52243882-74-6C26H28Cl2N6O
CVT-313199986-75-9C20H28N6O3
AT7519 Hydrochloride902135-91-5C16H18Cl3N5O2
PHA-793887718630-59-2C19H31N5O2
AUZ 454853299-07-7C24H26F3N7O2
THZ21604810-84-5C31H28ClN7O2
Dalcetrapib211513-37-0C23H35NO2S
CDKI-731421693-22-2C15H15FN6O2S2
MSC25308181883423-59-3C18H17ClN4O
Fadraciclib1070790-89-4C21H31N7O
CDK8-IN-41613638-82-6C20H18N4O
DB11132769753-53-7C59H68F3N13O6S
Anacetrapib875446-37-0C30H25F10NO3
RGB-286638784210-87-3C29H37Cl2N7O4
CK7507487-89-0C14H12N6O2S
BRD6989642008-81-9C16H16N4
THAL-SNS-0322139287-33-3C40H52N8O10S2
CDK12-IN-22244987-03-7C32H32N6O2
Abemaciclib1231929-97-7C27H32F2N8
CDK9-IN-21263369-28-3C23H25ClFN5
Narazaciclib1357470-29-1C24H27N7O
Palbociclib-d81628752-83-9C24H21D8N7O2
Trilaciclib1374743-00-6C24H30N8O
Indirubin-3′-oxime667463-82-3C16H11N3O2
AZD45732057509-72-3C22H28ClN5O2
NG 52212779-48-1C16H19ClN6O
FN-15011429515-59-2C22H25N9O
CDK4/6-IN-21800506-48-2C27H32F2N8
Eciruciclib1868086-40-1C27H33FN8
CD73-IN-42216764-29-1C16H23ClN5O7P
NCT02790245-61-3C17H16N2O2S
AT7519844442-38-2C16H17Cl2N5O2
Bisindolylmaleimide X hydrochloride145317-11-9C26H25ClN4O2
Ribociclib hydrochloride1211443-80-9C23H31ClN8O
THZ5311702809-17-3C30H32ClN7O2
SR-48352387704-62-1C21H20Cl2N10O
CDK9-IN-72369981-71-3C29H37N7O2S
SRI-293292086809-58-5C20H26ClN7
Milciclib802539-81-7C25H32N8O
Ribociclib succinate1374639-75-4C27H36N8O5
HS381030203-81-6C14H12ClN5O2S
NVP-21263373-43-8C27H37ClN6O2
LY31778331627696-51-8C16H12FN5O
Enitociclib1610358-56-9C19H18F2N4O2S
CC-6711618658-88-0C28H28N6O4
HS-243848249-10-5C17H16N4O3
SY-56092417302-07-7C23H26F3N6OP
Rintodestrant2088518-51-6C26H19FO5S
Ipivivint1481617-15-5C26H21FN8
AZ55762751721-40-9C21H24FN3O3
KH-CB201354448-60-4C15H13Cl2N3O2
PNU112455A hydrochloride21886-12-4C10H12ClN5O2S
CPS22756741-90-7C38H42N12O10S2
CDK4/6-IN-62380321-51-5C22H27ClFN5O3
CKI-7 free base120615-25-0C11H12ClN3O2S
NSC 10751222242-89-3C12H16N6O5
(E/Z)-Zotiraciclib hydrochloride1321626-25-8C23H25ClN4O
CDK7/12-IN-12654075-94-0C25H34N8O
CD73-IN-32375815-63-5C15H18N4O2
YKL-5-124 TFA2748220-93-9C30H34F3N7O5
BSJ-4-1162519823-34-6C40H49ClN8O8S
TNIK-IN-32754265-25-1C23H18FN3O2
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Copyright 2019 ? ChemicalBook. All rights reserved